Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1761-1770 of 2867 for cancer

Edit search filters
  1. A Study Of The Effectiveness And Safety Of Pembrolizumab (MK-3475) For Women With Advanced Recurrent Ovarian Cancer

    Rochester, MN

  2. A Study Of Rucaparib In Patients With Metastatic Castration-resistant Prostate Cancer And Homologous Recombination Gene Deficiency

    Scottsdale/Phoenix, AZ

  3. A Study Of ACP-196 Alone And In Combination With Pembrolizumab In Subjects With Advanced Or Metastatic Pancreatic Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone In Patients With Platinum Sensitive Ovarian Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. Safety And Tolerability Of TAR-200 In Subjects With Muscle-Invasive Bladder Cancer Who Are Unfit For Radical Cystectomy

    Scottsdale/Phoenix, AZ

  6. FES PET/CT In Predicting Response In Patients With Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine Therapy

    Rochester, MN

  7. Recombinant Human Papillomavirus Nonavalent Vaccine In Preventing Human Papillomavirus-Related Cancer In Adult Women After Kidney Transplant

    Rochester, MN

  8. A Study Of The Safety And Effectiveness Of Palbociclib Plus Cetuximab Versus Cetuximab Alone To Treat Head And Neck Cancer

    Rochester, MN

  9. Intensity-Modulated Radiation Therapy And Paclitaxel With Or Without Pazopanib Hydrochloride In Treating Patients With Anaplastic Thyroid Cancer

    Jacksonville, FL, Rochester, MN

  10. Gemcitabine Hydrochloride Alone Or With M6620 In Treating Patients With Recurrent Ovarian, Primary Peritoneal, Or Fallopian Tube Cancer

    Rochester, MN

.

Mayo Clinic Footer